| Study characteristics |
| Methods |
Multicentre double‐blind, randomized, placebo‐controlled |
| Participants |
CABG (n = 69); Aortic valve (n = 1); Mitral valve (n = 2); Aneurysm resection (n = 6); Other (n = 2) |
| Interventions |
Amiodarone vs. placebo |
| Outcomes |
AF lasting at least 30 minutes |
| Follow‐Up |
Not reported (30‐day mortality) |
| Concurrent Antiarrhythmic Medications |
Verapamil, diltiazem, Beta‐blockers |
| Notes |
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Unclear risk |
No randomization method mentioned |
| Allocation concealment (selection bias) |
Unclear risk |
Insufficient information |
| Blinding of participants and personnel (performance bias)
All outcomes |
Low risk |
Placebo‐controlled |
| Blinding of outcome assessment (detection bias)
All outcomes |
Low risk |
Placebo‐controlled |
| Incomplete outcome data (attrition bias)
All outcomes |
Low risk |
No missing outcome data |
| Selective reporting (reporting bias) |
Low risk |
All outcomes reported |
| Intention‐to‐treat analysis |
High risk |
No |
